DAS NICHT-KLEINZELLIGE BRONCHUSKARZINOM. DIAGNOSE, BEHANDLUNG UND PROGNOSEJOSS R; GOLDHIRSCH A; BRUNNER KW et al.1980; DTSCHE MED. WSCHR.; DEU; DA. 1980; VOL. 105; NO 21; PP. 766-770; BIBL. 24 REF.Article

KOMPLIKATIONEN IM BEREICH DER NIERE UND DER ABLEITENDEN HARNWEGE IM VERLAUF VON TUMORKRANKHIEITEN = COMPLICATIONS DANS LA REGION DU REIN ET DES VOIES URINAIRES AU COURS DES MALADIES TUMORALESJOSS R; GOLDHIRSCH A; BRUNNER K et al.1980; SCHWEIZ. MED. WSCHR.; CHE; DA. 1980; VOL. 110; NO 11; PP. 390-404; ABS. ENG; BIBL. 192 REF.Article

VINDESIN, EIN NEUES ZYTOSTATIKUM AUS DER REIHE DER VINCA-ALKALOIDE = VINDESINE, NOUVEAU CYTOSTATIQUE DE LA SERIE DES ALCALOIDES DE LA VINCAGOLDHIRSCH A; JOSS R; SONNTAG RW et al.1980; DTSCHE MED. WSCHR.; DEU; DA. 1980; VOL. 105; NO 26; PP. 931-935; BIBL. 41 REF.Article

DIE PROLYMPHOZYTAERE LEUKAEMIE: EINE NEUE KLINISCHE ENTITAET. EIN KASUISTISCHER BERICHT MIT UEBERSICHT UEBER DIE LITERATUR. = LA LEUCEMIE PROLYMPHOCYTAIRE: UNE NOUVELLE ENTITE CLINIQUE. UN RAPPORT DE CAS AVEC REVUE DE LA LITTERATURECAVALLI F; PEDRINIS E; LUDIN J et al.1977; DTSCHE MED. WSCHR.; DTSCH.; DA. 1977; VOL. 102; NO 41; PP. 1443-1445; ABS. ANGL.; BIBL. 23 REF.Article

PHASE II STUDY OF ORAL VP-16-213 IN HEPATOCELLULAR CARCINOMACAVALLI F; ROZENCWEIG M; RENARD J et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 10; PP. 1079-1082; BIBL. 19 REF.Article

Estrogen receptor in malignant melanoma: fact or artefact? = Récepteurs des œstrogènes dans le mélanome malin: réalité ou artefact?ZAVA, D. T; GOLDHIRSCH, A.European journal of cancer & clinical oncology. 1983, Vol 19, Num 8, pp 1151-1159, issn 0277-5379Article

ACUTE ERYTHROLEUKEMIA FOLLOWING CHEMOTHERAPY FOR HODGKIN'S DISEASEGOLDHIRSCH A; PIROVINO M; CONINX S et al.1980; AM. J. MED. SCI.; ISSN 0002-9629; USA; DA. 1980; VOL. 280; NO 1; PP. 53-56; BIBL. 24 REF.Article

Reporting and interpreting adjuvant therapy clinical trialsGELBER, R. D; GOLDHIRSCH, A.Journal of the National Cancer Institute. Monographs. 1992, Num 11, pp 59-69, issn 1052-6773Article

Computertomographie, primäre Laparotomie und second-look-Operation bei Ovarialkarzinom = Tomodensitométrie, laparotomie primaire et opération de seconde intention dans le cancer de l'ovaire = Computed tomography, primary laparotomy and «second-look» operation for ovarian carcinomaTRILLER, J; GOLDHIRSCH, A.RöFo. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 1984, Vol 140, Num 3, pp 294-303, issn 0340-1618Article

A quality-of-life-oriented endpoint for comparing therapiesGELBER, R. D; GELMAN, R. S; GOLDHIRSCH, A et al.Biometrics. 1989, Vol 45, Num 3, pp 781-795, issn 0006-341XArticle

Wertigkeit der Computertomographie in der Beurteilung von Lymphknotenmetastasen beim Ovarialkarzinom = Valeur de la tomodensitométrie dans l'évaluation des adénopathies métastatiques du cancer ovarien = The value of computed tomography for the demonstration of lymph node metastases due to carcinoma of the ovaryTRILLER, J; GOLDHIRSCH, A; FUCHS, W. A et al.RöFo. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 1984, Vol 141, Num 1, pp 35-39, issn 0340-1618Article

Adjuvant therapy of breast cancerGOLDHIRSCH, A; GELBER, R. D; CASTIGLIONE, M et al.European journal of cancer (1990). 1991, Vol 27, Num 3, pp 389-399, issn 0959-8049Conference Paper

COMBINATION CHEMOTHERAPY WITH VM-26, ADRIAMYCIN, BLEOMYCIN, AND PREDNISONE AS A SECONDARY TREATMENT OF MALIGNANT LYMPHOMAGOLDHIRSCH A; PIROVINO M; SONNTAG RW et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 335-337; BIBL. 11 REF.Article

Endocrine therapies of breast cancerGOLDHIRSCH, A; GELBER, R. D.Seminars in oncology. 1996, Vol 23, Num 4, pp 494-505, issn 0093-7754Article

LEVONANTRADOL, A NEW ANTIEMETIC WITH A HIGH RATE OF SIDE-EFFECTS FOR THE PREVENTION OF NAUSEA AND VOMITING IN PATIENTS RECEIVING CANCER CHEMOTHERAPYJOSS RA; GALEAZZI RL; BISCHOFF A et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 9; NO 1; PP. 61-64; BIBL. 12 REF.Article

UNGEWOEHNLICHE AUTOIMMUNE UND NEOPLASTISCHE BEGLEITERKRANKUNGEN BEI SJOEGREN-SYNDROM = MALADIES ASSOCIEES AUTOIMMUNES ET NEOPLASIQUES, INHABITUELLES DANS LE SYNDROME DE SJOEGRENREINER M; GOLDHIRSCH A; KAPLAN E et al.1979; SCHWEIZ. MED. WSCHR.; CHE; DA. 1979; VOL. 109; NO 45; PP. 1741-1742; ABS. ENG; BIBL. 9 REF.Article

Outcome and clinical―biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesMUNZONE, E; BOTTERI, E; GOLDHIRSCH, A et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2884-2890, issn 0923-7534, 7 p.Article

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsHUOBER, J; GELBER, S; GOLDHIRSCH, A et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2843-2851, issn 0923-7534, 9 p.Article

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerMUNZONE, Elisabetta; BOTTERI, E; LUINI, A et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 277-282, issn 0167-6806, 6 p.Article

Cancer-testis antigen expression in triple-negative breast cancerCURIGLIANO, G; VIALE, G; GHIONI, M et al.Annals of oncology. 2011, Vol 22, Num 1, pp 98-103, issn 0923-7534, 6 p.Article

Should liver metastases of breast cancer be biopsied to improve treatment choice?CURIGLIANO, G; BAGNARDI, V; DELLA VIGNA, P et al.Annals of oncology. 2011, Vol 22, Num 10, pp 2227-2233, issn 0923-7534, 7 p.Article

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialUNTCH, M; GELBER, R. D; DE AZAMBUJA, E et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1090-1096, issn 0923-7534, 7 p.Article

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerBERNHARD, J; ZAHRIEH, D; GREEN, M. D et al.British journal of cancer. 2008, Vol 98, Num 1, pp 25-33, issn 0007-0920, 9 p.Article

Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivorsSANNA, G; LORIZZO, K; ROTMENSZ, N et al.Annals of oncology. 2007, Vol 18, Num 2, pp 288-292, issn 0923-7534, 5 p.Article

A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancerTORRISI, R; ORLANDO, L; GHISINI, R et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3861-3864, issn 0250-7005, 4 p.Article